The Inpatient Medicine curriculum is a longitudinal, progressive educational program that reviews evidence-based medicine in the care of hospitalized patients. There is particular emphasis on research that impacts current practice guidelines (“landmark” trials). Residents are expected to engage in the curriculum during inpatient ward blocks through peer- and attending-led discussion of the material.
Back to the basics—this month we review management in multivessel CAD and COPD.
This month, we look at treatments for atrial fibrillation and rheumatoid arthritis. These treatments are commonly used for our patients at Olive View.
This month’s articles take a look back at treatments that have been or are still used, but that don’t have the strongest evidence as you might expect. Here are the landmark articles for treatments used in alcoholic hepatitis and contrast nephropathy.
This month, we take a look an important treatment in hematology: all-trans retinoic acid in acute promyelocytic anemia. It’s one of those associations that should always remember in oncology (much like x mutation is associated with y disease).